Clinical Trials Directory

Trials / Conditions / Lassa Fever

Lassa Fever

13 registered clinical trials studyying Lassa Fever — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingARN-75039 Lassa Fever Treatment in West Africa
NCT07419373
Arisan Therapeutics, Inc.Phase 2
RecruitingISTH/ANRS 0409s INTEGRATE Lassa Fever Study
NCT06212336
Irrua Specialist Teaching HospitalPhase 2 / Phase 3
Active Not RecruitingDMID 23-0015; Lassa Fever CVD 1000
NCT06546709
Wilbur Chen, MD, MSPhase 1
RecruitingA Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
NCT05868733
International AIDS Vaccine InitiativePhase 2
RecruitingLAssa Fever Adjunct Treatment With DEXamethasone
NCT06222723
Bernhard Nocht Institute for Tropical MedicinePhase 2
CompletedPharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Feve
NCT04907682
Bernhard Nocht Institute for Tropical MedicinePhase 2
UnknownA Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good Genera
NCT04794218
International AIDS Vaccine InitiativePhase 1
CompletedDose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana
NCT04093076
Inovio PharmaceuticalsPhase 1
CompletedCardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever
NCT04285034
University of Oxford—
CompletedSafety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers
NCT03805984
Inovio PharmaceuticalsPhase 1
TerminatedCardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever
NCT03889106
University of Oxford—
Active Not RecruitingLassa Fever Clinical Course and Prognostic Factors in Nigeria
NCT03655561
Alliance for International Medical Action—
WithdrawnTreatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
NCT00992693
U.S. Army Medical Research and Development CommandPhase 2